Burrill &a; Company

Burrill &a; Company is a venture capital and private equity firm that invests in life sciences, biotechnology, and healthcare companies.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Burrill &a; Company Information

Geographic Data

Burrill &a; Company headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Burrill &a; Company is a venture capital and private equity firm that invests in life sciences, biotechnology, and healthcare companies.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
11/2006 Natural Dentist Series B -
2/2013 Strand Life Sciences Series B -
5/2007 Arete Therapeutics Series A 35M
10/2005 Alinea Pharmaceuticals Series A 45M
11/2004 Neosil Series A 32M
8/2011 Ceptaris Therapeutics Series D 14.4M
6/2012 Ceptaris Therapeutics Series D 10M
4/2004 Efficas Series A 4.7M
1/2010 Endocyte Series C 26M
6/2009 Virdia Series A 5.5M
12/2000 Circe Biomedical Private Equity Round 28M
4/2012 WhiteGlove Health Series E 0
4/2009 Aerovance Venture Round 38M
5/2013 NewBridge Pharmaceuticals Series C 0
4/2006 Chromatin Venture Round 0
3/2012 Virdia Series A 20M
1/2007 diaDexus Post-IPO Equity 0
5/2010 Gevo Series D 0
8/2009 SchoolCare Series G 14.4M
9/2010 NewBridge Pharmaceuticals Series B 12M
10/2012 Cobalt Technologies Venture Round 5M
8/2009 Gevo Venture Round 0
4/2012 Cobalt Technologies Venture Round 2.9M
10/2001 GeneFormatics Venture Round 0
9/2002 Alexza Pharmaceuticals Series A 0
9/2007 Chlorogen Venture Round 0
6/2001 Corus Pharma Series A 18.5M
2/2000 DoubleTwist Series D 37M
8/2005 Chlorogen Series B 0
9/2004 Sciona Series B 4.1M
12/2005 SchoolCare Series E 26.5M
3/2007 Endocyte Series C 15M
3/2007 Aerovance Series C 60M
7/2007 Light Sciences Oncology Series B 30M
5/2008 Gevo Series C 17M
11/2006 Neurotech Series B 0
4/2014 Nora Therapeutics Series B 18M
11/2006 Endocyte Venture Round 30M
12/2006 Dreamerz Foods Series A 4M
6/2007 Dreamerz Foods Series B 10M
4/2012 WaveTec Vision Venture Round 0
11/2004 BioMimetic Therapeutics Series C 25.7M
8/2008 Wellpartner Series D 0
3/2007 ProteoGenix Series B 20M
6/2007 Logical Therapeutics Series B 30M
3/2014 Neos Therapeutics Series C 15.5M
4/2004 Cardiokine Series A 37M
2/2006 Catalyst Biosciences Series B 30M
8/2004 Aerovance Series B 32M
2/2005 Brand New Brands Series A 15M
1/2008 PrimeraDx (Primera Biosystems) Series B 21M
2/2013 Odyssey Thera Venture Round 0
4/2006 Sciona Series C 9.9M
4/2013 Catalyst Biosciences Post-IPO Equity 5.1M
6/2004 Nucleonics Series B 49.2M
1/2001 Bruker Post-IPO Equity 22.5M
10/2006 Morphotek Series D 0
11/2009 FerroKin Biosciences Venture Round 15M
6/2010 FerroKin Biosciences Series B 12M
12/2008 Catalyst Biosciences Post-IPO Equity 40M
6/2012 AliveCor Series B 0
12/2004 SchoolCare Series D 20M
10/2009 PrimeraDx (Primera Biosystems) Series C 20M
2/2004 Morphotek Series C 26M
2/2015 Neos Therapeutics Venture Round 20.6M
12/2002 Catalyst Bioscience Venture Round 46M
1/2005 Alexza Pharmaceuticals Series D 0
7/2003 Immunicon Series F 24.8M
5/2003 BioMimetic Therapeutics Series B 5M
4/2004 Corus Pharma Series C 0
8/2006 Intranasal Therapeutics Series A 0
8/2001 Morphotek Series B 0
1/2003 Emerald BioAgriculture Corporation Venture Round 0
5/2006 Cardiokine Series B 50M
3/2009 Intranasal Therapeutics Series B 0
9/2008 Osprey Pharmaceuticals USA Series A 11M
3/2008 NanoVasc Series A 4.7M
11/2012 MabVax Therapeutics Series B 5.3M
10/2013 BetterDoctor Seed Round 0
1/2004 Phytomedics Series A 7.5M
6/2007 Phytomedics Series B 9M
3/2004 Spectral Genomics Series B 9.3M
5/2001 BioMimetic Therapeutics Series A 6.5M
8/2012 Waterstone Pharmaceuticals Series B 3.4M
2/2012 ADMA Biologics Venture Round 0
5/2005 BioMimetic Therapeutics Series C 11.8M
9/2012 Catalyst Biosciences Post-IPO Equity 13.4M
1/2006 Adlyfe Series A 3.3M
8/2011 AliveCor Series A 0
8/2008 BioImagene Series D 26M
4/2007 Natural Dentist Series B 13.2M
2/2015 Neos Therapeutics Venture Round 0
4/2014 Nora Therapeutics Series B 0
3/2014 Neos Therapeutics Series C 0
10/2013 BetterDoctor Seed Round 0
5/2013 NewBridge Pharmaceuticals Series C 0
4/2013 Catalyst Biosciences Post-IPO Equity 0
2/2013 Strand Life Sciences Series B -
2/2013 Odyssey Thera Venture Round 0
11/2012 MabVax Therapeutics Series B 0
10/2012 Cobalt Technologies Venture Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research